Rare and Orphan Diseases

Episodes 17-32 of 32

Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Project Oncology®
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
- Joshua Brandstadter, MD, PhD, MSc
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
Project Oncology®
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
- Chenyu Lin, MD
- Charles Turck, PharmD, BCPS, BCCCP
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
CME/CE
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
1.00 credit
- Amir T. Fathi, MD
- Courtney DiNardo, MD
- Brian A. Jonas, MD, PhD
1.00 credit
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
- Betsy O'Donnell, MD
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
- Betsy O'Donnell, MD
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
- Matt Birnholz, MD
- Saad Kenderian M.B, Ch.B
WHIM Syndrome: A Chronic Neutropenic Disorder
WHIM Syndrome: A Chronic Neutropenic Disorder
MinuteCE®
WHIM Syndrome: A Chronic Neutropenic Disorder
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
MinuteCE®
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
1.00 program credit
- Jacob R. Bledsoe, MD
1.00 program credit
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
MinuteCE®
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
MinuteCE®
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
1.00 program credit
- Teresa K. Tarrant, MD
1.00 program credit
MinuteCE®
WHIM Syndrome (A Chronic Neutropenic Disorder): Uncouple the Complex for HCPs and Patients
1.00 credit 7 episodes
- Jolan Walter, MD, PHD
- Teresa K. Tarrant, MD
- Peter E. Newburger, MD
- Jacob R. Bledsoe, MD
1.00 credit 7 episodes
WHIM Syndrome: A Misguided Immune System!
WHIM Syndrome: A Misguided Immune System!
MinuteCE®
WHIM Syndrome: A Misguided Immune System!
1.00 program credit
- Peter E. Newburger, MD
1.00 program credit
WHIM Syndrome Management: The First FDA Approval for Patients
WHIM Syndrome Management: The First FDA Approval for Patients
MinuteCE®
WHIM Syndrome Management: The First FDA Approval for Patients
1.00 program credit
- Teresa K. Tarrant, MD
1.00 program credit
WHIM Syndrome Treatment: We Can Do Better!
WHIM Syndrome Treatment: We Can Do Better!
MinuteCE®
WHIM Syndrome Treatment: We Can Do Better!
1.00 program credit
- Jolan Walter, MD, PHD
1.00 program credit
Genetic Research into Hypodiploid ALL
Genetic Research into Hypodiploid ALL
Focus on Cancer
Genetic Research into Hypodiploid ALL
- Bruce Bloom, DDS, JD
- Charles Mullighan, MBBS, MSc, MD